세계의 비수술 코성형 시장 : 산업 규모, 점유율, 동향, 기회 및 예측 - 필러 유형별, 용도별, 최종 용도별, 지역별, 경쟁별(2020-2030년)

Global Non Surgical Rhinoplasty market was valued at USD 752.35 million in 2024 and is projected to reach USD 1,199.56 million by 2030, growing at a compound annual growth rate (CAGR) of 8.06% during the forecast period. This market has witnessed substantial growth and evolution in recent years, driven by the rising demand for non-invasive cosmetic enhancements. Increasingly, consumers are turning to non-surgical rhinoplasty-commonly known as the "liquid nose job"-as a preferred alternative to traditional surgical procedures.

This minimally invasive technique involves the use of injectable dermal fillers to reshape and enhance nasal contours without the need for surgery. The procedure is typically completed in under an hour and allows patients to resume daily activities almost immediately, offering an appealing solution for individuals with active lifestyles. Compared to surgical rhinoplasty, it offers significantly reduced recovery time, minimal risk, and instant, noticeable results-factors contributing to its growing popularity.

Market Drivers

Rising Demand for Minimally Invasive Aesthetic Procedures

The healthcare sector has been shifting toward less invasive treatment options, with consumers increasingly seeking alternatives to conventional surgery. This trend is supported by benefits such as shorter recovery periods, reduced procedural risks, and lower costs. According to the American Society of Plastic Surgeons (ASPS), minimally invasive cosmetic procedures in the U.S. increased by 7% in 2023, surpassing the growth rate of surgical treatments.

Non-surgical rhinoplasty has become a prominent trend within the broader aesthetic medicine space. Its appeal lies in the absence of incisions and sutures, resulting in lower levels of discomfort and downtime. The procedure offers a high degree of customization, allowing practitioners to tailor treatments to individual facial structures and patient preferences. As consumer interest grows, the market is expected to continue its upward trajectory, supported by ongoing advancements in technology and product development.

Market Challenges

Safety Concerns and Regulatory Variability

Despite its non-invasive nature, non-surgical rhinoplasty presents certain safety challenges that could hinder market expansion. The use of dermal fillers-primarily hyaluronic acid-carries risks such as vascular occlusion, which can lead to complications including tissue necrosis or vision impairment. The nasal area's complex vascular structure heightens the potential for adverse outcomes, especially when procedures are performed by inadequately trained or unlicensed individuals.

Additionally, inconsistent regulatory standards across regions contribute to variable treatment quality and outcomes. In some countries, oversight regarding qualified practitioners and approved materials is limited. The proliferation of counterfeit or substandard fillers further elevates the risk, leading to patient hesitation. Negative media coverage of botched procedures amplifies public concerns. Enhancing patient and provider education, standardizing training protocols, and implementing stricter regulations will be essential to build consumer confidence and ensure procedural safety.

Market Trends

Technological Advancements Driving Market Innovation

Technological innovation is playing a pivotal role in the evolution of the non-surgical rhinoplasty market. Recent developments in dermal filler formulations-particularly those using hyaluronic acid-have led to safer, more durable, and more effective products. These advancements have significantly improved patient satisfaction and procedural outcomes.

Cutting-edge tools such as 3D imaging and simulation software are transforming the consultation process, enabling both practitioners and patients to visualize expected results in advance. This not only enhances precision but also builds greater trust and transparency between provider and client.

Further, the emergence of needle-free injection systems is reducing discomfort and bruising, making the procedure even more accessible to needle-averse individuals. Long-lasting fillers that maintain their effects for up to two years are also gaining traction, offering a more cost-effective and convenient solution for patients.

As technology continues to advance, the non-surgical rhinoplasty market is expected to benefit from greater procedural efficiency, improved patient outcomes, and expanded treatment capabilities, positioning it for sustained growth.

Key Market Players

• Thermo Fisher Scientific, Inc.
• SKINovative of Gilbert - Medical Spa
• The London Cosmetic Clinic
• Laser Clinic United Kingdom
• Therapie Clinic
• Toronto Cosmetic Clinic (TCC)
• Canada MedLaser, Inc.
• Skin Vitality Medical Clinic
• True MediSpa Skin & Laser Clinic
• Nova Aesthetic Clinic
• VIVA Skin Clinic
• Piedmont Plastic Surgery & Dermatology

Report Scope:

In this report, the Global Non-surgical Rhinoplasty Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Non-surgical Rhinoplasty Supplements Market, By Filler Type:

• Hyaluronic Acid Filler
• CaHa Filler

Non-surgical Rhinoplasty Supplements Market, By Application:

• Convex Nose
• Indentations of dorsal hump
• Minor Nasal Asymmetry
• Others

Non-surgical Rhinoplasty Supplements Market, By End-use:

• MedSpa
• Hospital/Surgery Center
• HCP-owned Clinic

Non-surgical Rhinoplasty Supplements Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Non-surgical Rhinoplasty.

Available Customizations:

Global Non-surgical Rhinoplasty report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Non-surgical Rhinoplasty Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Filler Type (Hyaluronic Acid Filler, CaHa Filler)
  • 5.2.2. By Application (Convex Nose, Indentations of dorsal hump, Minor Nasal Asymmetry, Others)
  • 5.2.3. By End-use (MedSpa, Hospital/Surgery Center, HCP-owned Clinic)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Non-surgical Rhinoplasty Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Filler Type
  • 6.2.2. By Application
  • 6.2.3. By End-use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Non-surgical Rhinoplasty Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Filler Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-use
  • 6.3.2. Mexico Non-surgical Rhinoplasty Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Filler Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-use
  • 6.3.3. Canada Non-surgical Rhinoplasty Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Filler Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-use

7. Europe Non-surgical Rhinoplasty Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Filler Type
  • 7.2.2. By Application
  • 7.2.3. By End-use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Non-surgical Rhinoplasty Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Filler Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-use
  • 7.3.2. Germany Non-surgical Rhinoplasty Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Filler Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-use
  • 7.3.3. United Kingdom Non-surgical Rhinoplasty Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Filler Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-use
  • 7.3.4. Italy Non-surgical Rhinoplasty Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Filler Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-use
  • 7.3.5. Spain Non-surgical Rhinoplasty Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Filler Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-use

8. Asia-Pacific Non-surgical Rhinoplasty Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Filler Type
  • 8.2.2. By Application
  • 8.2.3. By End-use
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Non-surgical Rhinoplasty Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Filler Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-use
  • 8.3.2. India Non-surgical Rhinoplasty Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Filler Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-use
  • 8.3.3. South Korea Non-surgical Rhinoplasty Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Filler Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-use
  • 8.3.4. Japan Non-surgical Rhinoplasty Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Filler Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-use
  • 8.3.5. Australia Non-surgical Rhinoplasty Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Filler Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-use

9. South America Non-surgical Rhinoplasty Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Filler Type
  • 9.2.2. By Application
  • 9.2.3. By End-use
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Non-surgical Rhinoplasty Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Filler Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-use
  • 9.3.2. Argentina Non-surgical Rhinoplasty Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Filler Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-use
  • 9.3.3. Colombia Non-surgical Rhinoplasty Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Filler Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-use

10. Middle East and Africa Non-surgical Rhinoplasty Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Filler Type
  • 10.2.2. By Application
  • 10.2.3. By End-use
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Non-surgical Rhinoplasty Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Filler Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-use
  • 10.3.2. Saudi Arabia Non-surgical Rhinoplasty Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Filler Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-use
  • 10.3.3. UAE Non-surgical Rhinoplasty Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Filler Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. SKINovative of Gilbert - Medical Spa
• 14.3. The London Cosmetic Clinic
• 14.4. Laser Clinic United Kingdom
• 14.5. Therapie Clinic
• 14.6. Toronto Cosmetic Clinic (TCC)
• 14.7. Canada MedLaser, Inc.
• 14.8. Skin Vitality Medical Clinic
• 14.9. True MediSpa Skin & Laser Clinic
• 14.10. Nova Aesthetic Clinic
• 14.11. VIVA Skin Clinic
• 14.12. Piedmont Plastic Surgery & Dermatology

15. Strategic Recommendations

16. About Us & Disclaimer